Article citationsMore>>

J. P. Neoptolemos, W. Greenhalf, P. Ghaneh, D. H. Palmer, T. F. Cox, et al., “HENT1 Tumor Levels to Predict Survival of Pancreatic Ductal Adenocarcinoma Patients who Received Adjuvant Gemcitabine and Adjuvant 5FU on the ESPAC Trials,” Journal of Clinical Oncology, Vol. 31, Suppl. 4006, 2013.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top